Skip to main content

Table 4 In vitro susceptibilities of rare clinical species (n = 1) to four antifungal agents

From: Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry

Strains

Antifungal agent

MIC (μg/ml)

C. parapsilosis

Fluconazole

0.25

Amphotericin B

0.125 μg/ml

Caspofungin

4

Anidulafungin

0.25

Pichia kluyveri

(Candida eremophila)

Fluconazole

0.5

Amphotericin B

1

Caspofungin

4

Anidulafungin

0.25

Clavispora lusitaniae

(Candida lusitaniae)

Fluconazole

0.5

Amphotericin B

0.016

Caspofungin

2

Anidulafungin

0.25

Saccharomyces cerevisiae

Fluconazole

0.5

Amphotericin B

0.016

Caspofungin

4

Anidulafungin

0.25

Saprochaete capitata

Fluconazole

1

Amphotericin B

4

Caspofungin

0.125

Anidulafungin

0.016